secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001193125-26-206347
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics Q1 revenue up 21% but net income plunges 71% YoY; guidance reiterated
--------------------------------------------------------------------------------

- Revenue $173.9M (+21% YoY); net income $7.3M ($0.20 diluted EPS), down 71% from $0.70.
- Adjusted net income $10.9M ($0.30 diluted EPS), down 59% YoY.
- Operating margin 7.6% vs 19.1% prior year; adjusted operating margin 10.4%.
- Reiterates FY 2026 revenue guidance $727M-$757M.
- Announced investment in PAD Aviation to create European transplant logistic network; owns 22 aircraft.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312526206347/0001193125-26-206347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312526206347/tmdx-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-206347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer